SANUWAVE Health, Inc.
SANUWAVE Health, Inc.
Your view on SNWV
Overview
What the company does, where it operates, and who runs it.
About SANUWAVE Health, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Morgan C. Frank
- Headquarters
- 3360 Martin Farm Road, Suwanee, GA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Morgan C. Frank
- Headquarters
- 3360 Martin Farm Road, Suwanee, GA, US
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.
Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers.
Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration.
The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions.
In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures.
The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for SANUWAVE Health, Inc., and the rating behind it. SNWV last traded at $4.10, 2.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for SANUWAVE Health, Inc.. Starting points for SANUWAVE Health, Inc.: P/E 2.4, EPS $1.66, beta 1.50 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for SANUWAVE Health, Inc.. Trailing twelve-month EPS for SANUWAVE Health, Inc. stands at $1.66. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
SANUWAVE Health, Inc. valued side by side against its closest peers. SANUWAVE Health, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold SANUWAVE Health, Inc., and how their positions are changing. At a $35.3M market value, institutional positions materially move SANUWAVE Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by SANUWAVE Health, Inc. executives and directors. Shares of SANUWAVE Health, Inc. have traded between $18.50 and $46.59 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming SANUWAVE Health, Inc.. SANUWAVE Health, Inc. is a $35.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming SANUWAVE Health, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for SANUWAVE Health, Inc.. Coverage tracks SANUWAVE Health, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.